Clinical trial

Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer

NCT00095589 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Completed

Key facts

NCT number NCT00095589
Title Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer
Official title Detection of Bladder Cancer by Microsatellite Analysis (MSA) of Urinary Sediment: Multi-Institutional Study
Lead sponsor Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Study type Observational
Conditions Bladder Cancer
Intervention type Genetic, Other, Procedure
Interventions loss of heterozygosity analysis, microarray analysis, microsatellite instability analysis, cytology specimen collection procedure, laboratory biomarker analysis, computed tomography, cystoscopy
Enrollment 125
Start date Aug 1, 2004
Primary completion Jun 1, 2009
Completion Jun 1, 2009
First posted Nov 8, 2004
Last update posted Feb 8, 2019
Countries Canada, United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies